Literature DB >> 28041647

Information, social support and coping in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension-A nationwide population-based study.

Bodil Ivarsson1, Göran Rådegran2, Roger Hesselstrand3, Barbro Kjellström4.   

Abstract

OBJECTIVE: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) decrease life expectancy for affected patients. The aim was to describe the perceptions of received information regarding diagnosis, treatment and management, as well as social support and coping perceived by patients with PAH or CTEPH.
METHODS: A descriptive, national cohort survey that included patients from all PAH-centres in Sweden. A quantitative methodology was employed where all patients received three questionnaires, QLQ-INFO25, Mastery Scale and Social Network & Support Scale.
RESULTS: The response rate was 74% (n=325), mean age 66±14years, 71% were female and 69% were diagnosed with PAH and 31% with CTEPH. Sixty percent of respondents were satisfied with the received information and felt it was helpful. Best experiences were of information in the areas of medical tests (70%) and the disease (61%). Forty-five percent wanted more information. Men described their social network as more accessible than women (p=0.004). Those living alone had a lower coping ability.
CONCLUSION: Despite a high level of satisfaction with the received information, almost half of the patients wanted more information. PRACTICE IMPLICATIONS: Regular repeating or giving new information should be an ongoing process in the care of patients at the PAH-centres.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chronic illness; Communication; Mastery; Professionals-patient relations pulmonary hypertension; Social support

Mesh:

Year:  2016        PMID: 28041647     DOI: 10.1016/j.pec.2016.12.021

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  8 in total

1.  Participation in pulmonary hypertension support group improves patient-reported health quality outcomes: a patient and caregiver survey.

Authors:  Paresh C Giri; Gizelle J Stevens; Jeanette Merrill-Henry; Udochukwu Oyoyo; Vijay P Balasubramanian
Journal:  Pulm Circ       Date:  2021-05-17       Impact factor: 3.017

2.  Coping, social support and information in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A 2-year retrospective cohort study.

Authors:  Bodil Ivarsson; Göran Rådegran; Roger Hesselstrand; Barbro Kjellström
Journal:  SAGE Open Med       Date:  2018-01-04

3.  Exploring the experiences and psychosocial stresses of Taiwanese patients with pulmonary hypertension: a qualitative interview study.

Authors:  Yung-Chih Chiang; Li-Yu Hu; Jeremy Couper; Chin-Chang Cheng; Ling-Hsiang Wang; Wei-Chun Huang; Ti Lu
Journal:  Pulm Circ       Date:  2018-06-19       Impact factor: 3.017

4.  The importance of patient perspectives in pulmonary hypertension.

Authors:  Michael D McGoon; Pisana Ferrari; Iain Armstrong; Migdalia Denis; Luke S Howard; Gabi Lowe; Sanjay Mehta; Noriko Murakami; Brad A Wong
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

Review 5.  Patient-Reported Outcome Measures With Secondary Lower Limb Lymphedemas: A Systematic Review.

Authors:  Margit Eidenberger
Journal:  J Adv Pract Oncol       Date:  2021-03-01

6.  Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.

Authors:  Barbro Kjellström; Anna Sandqvist; Clara Hjalmarsson; Magnus Nisell; Per Näsman; Bodil Ivarsson
Journal:  ERJ Open Res       Date:  2020-12-07

7.  The Odyssey from Symptom to Diagnosis of Pulmonary Hypertension from the Patients and Spouses Perspective.

Authors:  Bodil Ivarsson; Anders Johansson; Barbro Kjellström
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

8.  Health-related quality of life, treatment adherence and psychosocial support in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.

Authors:  Bodil Ivarsson; Roger Hesselstrand; Göran Rådegran; Barbro Kjellström
Journal:  Chron Respir Dis       Date:  2018-07-16       Impact factor: 2.444

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.